419 related articles for article (PubMed ID: 26066671)
1. Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.
Bao Y; Cao X
Clin Rev Allergy Immunol; 2016 Jun; 50(3):301-11. PubMed ID: 26066671
[TBL] [Abstract][Full Text] [Related]
2. An epigenetic view of B-cell disorders.
Alberghini F; Petrocelli V; Rahmat M; Casola S
Immunol Cell Biol; 2015 Mar; 93(3):253-60. PubMed ID: 25601271
[TBL] [Abstract][Full Text] [Related]
3. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of estrogen in B cell malignancies.
Ladikou EE; Kassi E
Leuk Lymphoma; 2017 Mar; 58(3):528-539. PubMed ID: 27557932
[TBL] [Abstract][Full Text] [Related]
5. VLA-4 Expression and Activation in B Cell Malignancies: Functional and Clinical Aspects.
Härzschel A; Zucchetto A; Gattei V; Hartmann TN
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210016
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic control of early lymphocyte development.
Ikawa T
Curr Top Microbiol Immunol; 2014; 381():1-20. PubMed ID: 24850218
[TBL] [Abstract][Full Text] [Related]
7. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers.
Andrews JM; Pyfrom SC; Schmidt JA; Koues OI; Kowalewski RA; Grams NR; Sun JJ; Berman LR; Duncavage EJ; Lee YS; Cashen AF; Oltz EM; Payton JE
EBioMedicine; 2021 Sep; 71():103559. PubMed ID: 34461601
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic events during B lymphocyte development.
Parra M
Epigenetics; 2009 Oct; 4(7):462-8. PubMed ID: 19875937
[TBL] [Abstract][Full Text] [Related]
9. Complementary regulation of early B-lymphoid differentiation by genetic and epigenetic mechanisms.
Yokota T; Sudo T; Ishibashi T; Doi Y; Ichii M; Orirani K; Kanakura Y
Int J Hematol; 2013 Oct; 98(4):382-9. PubMed ID: 23999941
[TBL] [Abstract][Full Text] [Related]
10. Regulation of T cell differentiation and function by epigenetic modification enzymes.
Liu H; Li P; Wei Z; Zhang C; Xia M; Du Q; Chen Y; Liu N; Li H; Yang XP
Semin Immunopathol; 2019 May; 41(3):315-326. PubMed ID: 30963214
[TBL] [Abstract][Full Text] [Related]
11. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
Puri KD; Di Paolo JA; Gold MR
Int Rev Immunol; 2013 Aug; 32(4):397-427. PubMed ID: 23886342
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Epigenetic Regulation of Immune System during Aging.
Jasiulionis MG
Front Immunol; 2018; 9():197. PubMed ID: 29483913
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders.
da Costa TP; El-Cheikh MC; Carneiro K
J Immunol Res; 2020; 2020():1589191. PubMed ID: 32090127
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the Complexity of 3D Chromatin Organization Driving Lymphopoiesis and Lymphoid Malignancies.
Scourzic L; Salataj E; Apostolou E
Front Immunol; 2021; 12():669881. PubMed ID: 34054841
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells.
Hedrich CM; Crispin JC; Tsokos GC
Autoimmunity; 2014 Jun; 47(4):234-41. PubMed ID: 24762298
[TBL] [Abstract][Full Text] [Related]
18. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
[TBL] [Abstract][Full Text] [Related]
19. Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Fowler NH; Cheah CY; Gascoyne RD; Gribben J; Neelapu SS; Ghia P; Bollard C; Ansell S; Curran M; Wilson WH; O'Brien S; Grant C; Little R; Zenz T; Nastoupil LJ; Dunleavy K
Haematologica; 2016 May; 101(5):531-40. PubMed ID: 27132279
[TBL] [Abstract][Full Text] [Related]
20. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
Dominguez PM; Teater M; Shaknovich R
Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
